RxDoctor Payments DataLook up a doctor →

Myron Lewis, MD

Family Medicine · Huntington, WVNPI 1871525121

Payments from drug & device makers

$16,523in general payments, 2019–2025

Across 1,219 payments — averaging $13.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Novo Nordisk$1K
  • Novartis$1K
  • Lilly USA, LLC$1K
  • Amgen$872
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$16,523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)79$2,206
AbbVie(2 entities)121$1,609
Novo Nordisk178$1,434
Novartis104$1,403
Lilly USA, LLC68$1,045
Amgen67$872
GSK55$853
E.r. Squibb & Sons, L.L.C.68$741
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC46$513
Johnson & Johnson(2 entities)59$508
Boehringer Ingelheim43$495
Amarin Pharma, Inc.28$372
Takeda Pharmaceuticals U.S.A., Inc.21$356
Pfizer25$322
Teva Pharmaceuticals USA, Inc.21$318
Shield Therapeutics Inc10$308
Bayer14$268
Otsuka America Pharmaceutical, Inc.24$266
Esperion Therapeutics, Inc.19$243
Avanir Pharmaceuticals, Inc.27$231
Vifor Pharma, Inc.18$224
Paratek Pharmaceuticals, Inc.12$199
Kowa Pharmaceuticals America, Inc.21$159
Dexcom, Inc.9$145
Argenx US, Inc.7$135
Biohaven Pharmaceuticals, Inc.6$104
Abbott4$94
Mylan Specialty L.p.4$86
Sunovion Pharmaceuticals Inc.4$65
Daiichi Sankyo Inc.3$63
Intercept Pharmaceuticals, Inc.4$63
Sanofi-aventis U.S. LLC4$63
Merck3$58
Endo Pharmaceuticals Inc.3$48
Cvrx, Inc.3$44
Genentech USA, Inc.3$43
Melinta Therapeutics, LLC3$43
Corcept Therapeutics3$39
Xeris Pharmaceuticals, Inc.2$39
Lundbeck LLC2$34
Smith+Nephew2$33
Biohaven Pharmaceutical Holding Company Ltd.2$32
Astellas Pharma US Inc2$30
Aurinia Pharma U.S., Inc.1$28
Philips North America LLC1$23
Biogen1$22
Halozyme Inc1$21
Baxter Healthcare1$21
Scpharmaceuticals Inc.1$19
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$18
Exact Sciences1$18
Advanced Respiratory, Inc1$17
Sanofi Pasteur Inc.1$16
Organon1$16
Shire North American Group Inc1$15
Boston Scientific1$14
Phathom Pharmaceuticals, Inc.1$14
Ironwood Pharmaceuticals, Inc1$14
Incyte Corporation1$14
Neurocrine Biosciences, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,523 in reported general payments places this provider in the 95th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$136,776
Medicare patients
396
Services billed
1,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban123$97,738
JanuviaSitagliptin Phosphate74$92,730
OzempicSemaglutide40$65,338
JardianceEmpagliflozin36$40,439
XareltoRivaroxaban28$37,466
MounjaroTirzepatide26$34,708
ViberziEluxadoline13$18,669
FarxigaDapagliflozin Propanediol17$13,935
Breo ElliptaFluticasone/Vilanterol16$11,735
EntrestoSacubitril/Valsartan12$7,279
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,507
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen266$5,748
SymbicortBudesonide/Formoterol Fumarate12$4,672
Atorvastatin Calcium592$4,491
Fluticasone-SalmeterolFluticasone Propion/Salmeterol38$4,458

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$322$97,738123 claims
MerckJanuvia$58$92,73074 claims
Novo NordiskOzempic$1,434$65,33840 claims
Boehringer IngelheimJardiance$495$40,43936 claims
Johnson & JohnsonXarelto$508$37,46628 claims
Lilly USA, LLCMounjaro, Humalog$1,045$36,82347 claims
AbbVieViberzi, Synthroid$1,609$21,68356 claims
AstraZenecaFarxiga, Symbicort$2,206$18,60729 claims
GSKBreo Ellipta, Anoro Ellipta$853$18,24230 claims
NovartisEntresto$1,403$7,27912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →